what length does it take to to get to the sun
Doctoral Project Charter
Implementation of opioid risk assessment tool from a multidisciplinary pain management approach age group 18 and older
Part 1 |
||||||||||||||||||||||||||||||
General Project Information |
||||||||||||||||||||||||||||||
|
Project Name |
Implementation of opioid risk assessment tool from a multidisciplinary pain management approach age group 18 and older |
|||||||||||||||||||||||||||||
|
Executive Sponsors |
The chief director of healthcare information Technology was selected for the project to communicate as well as sell the vision for modern analytics in the company. The World Health Organization officials and key stakeholders are selected due to their fiscal and healthcare capability to endorse any kind of activity for enhanced efficiency. |
|||||||||||||||||||||||||||||
|
Department Sponsors |
The departmental managers will be considered to represent the distinct interests of their department for funding and budgeting. The healthcare coordinator will harmonize efforts and collaborate with objectives to enhance project success and feasibility. |
|||||||||||||||||||||||||||||
|
Project Aim |
The project aims to offer the most appropriate recommendations for the primary care clinicians involved in the prescription of opioids for chronic pain for age groups 18 years and older. The project is associated with offering the most comprehensive knowledge on when to begin or even progress with opioids for any kind of chronic pain and opioid selection, dosage, the durations, follow up activities and discontinuation. It also assesses the critical risk as well as addressing the harms associated with opioid use. |
|||||||||||||||||||||||||||||
|
Focus |
The recommendations and any knowledge offered will be made on the project as in the case of the systematic reviews regarding scientific evidence while considering the advantages and disadvantages, the values and preferences and the resource allocation. |
|||||||||||||||||||||||||||||
Project Team |
||||||||||||||||||||||||||||||
|
|
Title |
Department |
Credentials |
Role |
||||||||||||||||||||||||||
|
Project Manager |
Chief Healthcare Nurse |
Medical Department |
PhD in Healthcare Management and Pharmacy |
Will be in charge of every review and approval of any recommendation identified for enhanced efficiency and success of the whole project. |
||||||||||||||||||||||||||
|
Team Members |
Primary Care Clinicians |
Medical Department |
ASN |
To highlight the key gains and risks associated with opioid pain medication and follow instructions on the most appropriate way to deal with the issue. |
||||||||||||||||||||||||||
|
|
Clinical director |
Medical Department |
RN, BSN |
To act as the leader in the whole project and ensure that all the instructions are followed to the latter. It will help in providing that all the roles given to the individuals are handled most appropriately. |
||||||||||||||||||||||||||
|
|
Healthcare workers |
Medical department |
ASN |
To offer suggestions on the most appropriate risk assessment tools and to help in facilitating efficiency as well as feasibility in the whole operations. |
||||||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||||||
Stakeholders |
||||||||||||||||||||||||||||||
|
Stakeholder |
Outcomes |
|||||||||||||||||||||||||||||
|
Healthcare Staff |
The healthcare staff will benefit by having fewer admission cases on severe implications associated with the misuse of opioid medication for pain management. There will also be fewer cases for addiction on the same. |
|||||||||||||||||||||||||||||
|
Patients |
Patient satisfaction as they will get the most suitable medication and intervention for use in pain management without having to experience the negative implications associated with opioid medication. |
|||||||||||||||||||||||||||||
|
IT team and managers |
The team will benefit from fewer hours and time to review the documentation on opioid medication and implement better systems to monitor the same since the primary step will have been done most effectively. |
|||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||
Part 2 |
||||||||||||||||||||||||||||||
|
Project Overview |
||||||||||||||||||||||||||||||
|
Project Description |
||||||||||||||||||||||||||||||
|
Opioids are usually used for pain management. About 20% of the patients that present themselves to the physician offices with the non-cancer signs and symptoms for pain associated diagnoses are usually given opioid prescriptions. The identified rates regarding the opioid prescription are considered to be highly varied across different states in a manner that cannot in any way be explained by the recognized underlying health-associated status regarding the population, illustrating the lack of effective consensus among the identified clinicians on how to utilize opioid pain associated medication (Benzing et al., 2020). The project is focused on the prevention as well as assessment and the treatment of chronic pain using the proper method other than opioid cases except in some exceptional circumstances as it is becoming a challenge for the health care providers and systems and the patients. They are of 18 years and above. The use of guidelines in addressing the problem and prescribing is likely to enhance the optimization of care along with improving patient safety based on the evidence-based associated practice along with reversing the cycle regarding opioid pain associated medication misuse, which leads to the identified opioid overdose type of epidemic (Benzing et al., 2020). |
||||||||||||||||||||||||||||||
|
Evidence to Support Need |
||||||||||||||||||||||||||||||
|
Chronic pain has been effectively and variably defined, but it is usually identified within various guidelines as the type of persistent pain for more than three months or even goes beyond the normal time for healing. Chronic pain can be identified as an outcome of the underlying illness or even medical condition, injury, the specified medical treatment, or even an unknown cause. Estimates regarding the prevalence of chronic pain are considered to vary. Still, it is comprehensive that the identified number of individuals that experience chronic pain in the US is substantial (Echeverria-Villalobos et al., 2020). Clinicians need to consider the whole range regarding the therapeutic options for the identified treatment of chronic pain. However, it is challenging to estimate the specified number associated with the individual who could benefit from the use of opioid pain medication in the long term. Evidence shows that short term effectiveness regarding opioids for the reduction of pain and enhancing function in non-cancer nociceptive and neuropathic pain in the randomized clinical trials. However, few studies show the long-term benefits of opioid pain medication (Echeverria-Villalobos et al., 2020). The opioid pain medication utility is associated with the presentation of serious risks, inclusive of overdose and opioid utility disorder. The data rates associated with the use of opioid pain medication has been increasing remarkably. The sales related to opioid pain medication has been rising parallel to the opioid associated overdose deaths. Even though the clinical trials have been variable over time, the opioid utility disorder is defined as being a problematic pattern associated with opioid utility causing clinically essential impairment or even distress. The identified disorder is usually manifested by particular criteria like ineffective efforts to minimize or even control the utility and the utility as an outcome of social issues and the failure to fulfil critical obligations at work, school, and home. |
||||||||||||||||||||||||||||||
|
Project Purpose/Business Case |
||||||||||||||||||||||||||||||
|
The project aims to offer recommendations for the prescription of opioid pain medication by the identified ordinary care clinicians for any kind of chronic pain for patients who are 18 years and above. The project uses the risk assessment tool to analyze the various risks and threats of using opioid pain medication, especially in the long term. Even though the project does not focus on the identified pain management, effective utility regarding the long-term opioid therapy needs to be considered within the specified context regarding all pain management techniques, including the non-opioid pain types of medications and the non-pharmacologic treatments (Rao et al., 2020). The risk assessment is made on the emerging evidence from Scientific reviews. |
||||||||||||||||||||||||||||||
|
SMART Objectives (Specific, Measurable, Attainable, Relevant, Time-Bound) |
||||||||||||||||||||||||||||||
|
The project aims to enhance communication between the identified clinicians and patients regarding the various risks and benefits associated with opioid use disorder, overdose, and death. The goal is to use the most appropriate evidence available to come up with the best risk assessment of the long term use associated with opioid pain medication and offer the best recommendations on the same to enhance efficacy in pain management both in the short term and in the long term in the patients who are 18 years and above. |
||||||||||||||||||||||||||||||
|
Deliverables |
||||||||||||||||||||||||||||||
|
1. Effective and continuous risk assessment on opioid pain management. 2. Implementation of the most appropriate recommendations practices for risk prevention purposes. 3. Evaluation of the non-pharmacologic options for enhanced efficiency and effectiveness. |
||||||||||||||||||||||||||||||
|
Project Scope |
||||||||||||||||||||||||||||||
|
The project is intended for the primary care clinicians, that is, the family physicians and the internists involved in the treatment of the patients suffering from chronic pain in the outpatient settings. Prescriptions by the identified primary care clinicians usually account for about half of the dispensed opioid type of prescriptions. The development in the prescribing rates among these types of clinicians has been considered above average (Boyd et al., 2020). The key focus is on the primary care types of clinicians since the identified clinicians usually operate within the recognised team associated and the identified recommendations refer to and promote integrated pain associated management and even the collaborative working relationship with the other types of providers. The project intends to be applied to patients who are of ages 18 and above and suffering from chronic pain. The project is not aimed at the patients involved in active cancer-associated treatments and palliative care or even the end of life care since there are unique therapeutic goals and ethical considerations and a balance of risks and advantages in such situations. |
||||||||||||||||||||||||||||||
|
Project Milestones |
||||||||||||||||||||||||||||||
|
· Project Milestones.
|
||||||||||||||||||||||||||||||
Part 3 |
||||||||||||||||||||||||||||||
|
SWOT Analysis |
||||||||||||||||||||||||||||||
|
Strengths |
||||||||||||||||||||||||||||||
|
The project is highly supported by the executive team, who have committed themselves and their resources to ensure the success of the entire project, which is a good thing because it will increase the project's feasibility. Financial resources is another strength of the project since it has financially stable executive sponsors who, through their financial help, will be vital in ensuring that the project activities are carried out effectively. The availability of research resources is another critical strength because there are numerous websites, scientific journals, and articles available for the facilitation of the research.
|
||||||||||||||||||||||||||||||
|
Weaknesses |
||||||||||||||||||||||||||||||
|
Time constraints as the project have a limited time to complete and implement the same, which may cause inefficiencies in the data collection and result analysis. |
||||||||||||||||||||||||||||||
|
Opportunities |
||||||||||||||||||||||||||||||
|
The research is being carried out during a technological era that is filled with numerous and effective technological advancements; thus, there is the opportunity to use the current technology to research effectively and implement the outcomes. |
||||||||||||||||||||||||||||||
|
Threats |
||||||||||||||||||||||||||||||
|
Complexities in technology concepts may confuse the use and the interpretation of data for maximum project outcomes. Ineffective communication practices such as delayed practices or even lack of communication can cause overall delays in the project as per the task schedule. |
||||||||||||||||||||||||||||||
|
Known Major Risks |
||||||||||||||||||||||||||||||
|
Rank the SWOT weaknesses and threats listed above here. Identify at least one high risk and discuss how it might be mitigated. |
||||||||||||||||||||||||||||||
|
Risk Level (Low, Medium, High) |
Risk |
|||||||||||||||||||||||||||||
|
High |
Complexities in technology are high risk because any kind of mistake or error in the technology use can lead to severe negative implications in the overall project and project failure. |
|||||||||||||||||||||||||||||
|
Medium |
Time constraints are a medium risk because when the right measures are put in place, time can be used in the most effective way for enhanced maximum outcomes. |
|||||||||||||||||||||||||||||
|
Ethical Considerations |
||||||||||||||||||||||||||||||
|
The ethical considerations of the project entail the practice of honesty in relaying information by not using any obsolete information nor any incorrect information and ensuring that facts support all given information. Another ethical consideration is writing down information given by participants and not changing anything to avoid confusion. |
||||||||||||||||||||||||||||||
|
Constraints |
||||||||||||||||||||||||||||||
|
The project's key aim is to ensure reduced levels of intake of opioid medication by elderly patients. Still, the issue is that it may become hard to control the number of patients and the number of times and doses that these patients take opioid medication outside the clinical setting. |
||||||||||||||||||||||||||||||
|
External Dependencies |
||||||||||||||||||||||||||||||
|
The external dependencies, in this case, are the reviews and scientific resources that are available for use in the research process. This means that if external reviews and scientific resources offer biased or inappropriate information, the overall information will be compromised, and less accuracy will be realized in the data collected. |
||||||||||||||||||||||||||||||
|
Communication Strategy |
||||||||||||||||||||||||||||||
|
The communication will be carried out via video conferences. Due to the ongoing pandemic, it is hard to hold a face to face meeting. This will also help ensure that everyone is flexible enough to attend the conference and receive the information being relayed. Emails will also be used the reinforce the communication activities. |
||||||||||||||||||||||||||||||
|
Proposed Outcomes |
||||||||||||||||||||||||||||||
|
Metric |
Outcome Measure |
Process Measure |
Countermeasure (optional) |
|||||||||||||||||||||||||||
|
Low number of prescriptions on opioid pain medication |
Low percentage rate of below 25% |
Compliance to the recommendations |
Regular evaluations |
|||||||||||||||||||||||||||
|
Use of alternative pain medication |
Increased use of other pain medication available |
Higher supply of other recommended pain medication |
Analysis of the pain medication supplied by type. |
|||||||||||||||||||||||||||
|
Data Collection Plan |
||||||||||||||||||||||||||||||
|
The data will be collected from the voluntary participants who are already in the healthcare field. Moreover, scientific resources will be used to achieve enhanced feasibility and efficiency in the whole project. Interview and a survey method will be used on the participants, and the answers will be kept confidential. This will help in arriving at the most suitable data findings. Excel sheets will be used to create histograms and pie charts for the analysis of the collected data. |
||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
|
|
References
Benzing, A. C., Bell, C., Derazin, M., Mack, R., & MacIntosh, T. (2020). Disparities in opioid pain management for long bone fractures. Journal of Racial And Ethnic Health Disparities, 7(4), 740-745.
Boyd, C., Shew, M., Penn, J., Muelleman, T., Lin, J., Staecker, H., & Wichova, H. (2020). Postoperative opioid use and pain management following otologic and neurotologic surgery. Annals of Otology, Rhinology & Laryngology, 129(2), 175-180.
Echeverria-Villalobos, M., Stoicea, N., Todeschini, A. B., Fiorda-Diaz, J., Uribe, A. A., Weaver, T., & Bergese, S. D. (2020). Enhanced recovery after surgery (ERAS): a perspective review of postoperative pain management under ERAS pathways and its role on opioid crisis in the United States. The Clinical Journal of Pain, 36(3), 219-226.
Rao, R., Jackson, R. S., Rosen, B., Brenin, D., Cornett, W., Fayanju, O. M., ... & Froman, J. (2020). Pain control in breast surgery: survey of current practice and recommendations for optimizing management—American Society of Breast Surgeons Opioid/Pain Control Workgroup. Annals of Surgical Oncology, 27(4), 985-990.
1
17